Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)

NACompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

October 31, 2011

Conditions
Carotid Artery Disease
Interventions
DEVICE

Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3)

All subjects will receive the Xact™ Rapid Exchange Carotid Stent System. The first 220 consecutively enrolled subjects will be treated with the investigational filter system, the Emboshield® Pro Rapid Exchange Embolic Protection System (Generation 5). The remaining subjects will be treated with the FDA approved Emboshield® BareWire™ Rapid Exchange Embolic Protection System (Generation 3).

Trial Locations (38)

10021

Lenox Hill Hospital, New York

14209

Millard Fillmore Hospital-Kaleida Health Systems, Buffalo

17110

Pinnacle Health Hospital, Harrisburg

18105

Lehigh Valley Hospital, Allentown

19610

St. Joseph's Medical center, Wyomissing

20912

Washington Adventist Hospital, Takoma Park

23226

Bon Secours St. Mary's Hospital, Richmond

23507

Chesapeake General Hospital, Norfolk

27610

WakeMed Hospital, Raleigh

29605

Greenville Memorial Medical Center, Greenville

32216

Memorial Hospital Jacksonville, Jacksonville

33805

Lakeland Regional Medical Center, Lakeland

34475

Munroe Regional Medical Center, Ocala

37660

Holston Valley Medical Center, Kingsport

37934

Mercy Medical Center West / Baptist Hospital of East Tennessee, Knoxville

46260

St. Vincent Hospital and Health Care Center, Indianapolis

46805

Parkview Hospital, Fort Wayne

48073

William Beaumont Hospital, Royal Oak

48106

St. Joseph Mercy Hospital, Ann Arbor

48439

Genesys Regional Medical Center, Grand Blanc

48532

McLaren Regional Medical Center, Flint

53215

St. Luke's Medical Center, Milwaukee

60611

Northwestern University Memorial Hospital, Chicago

62701

St. John's Hospital / Memorial Medical Center, Springfield

70360

Terrebonne General Medical Center, Houma

75231

Presbyterian Heart Institute, Dallas

77030

St. Luke's Episcopal Hospital, Houston

78756

Austin Heart P.A., Austin

92663

Hoag Memorial Hospital Presbyterian, Newport Beach

94040

El Camino Hospital, Mountain View

94305

Stanford University Medical Center, Stanford

94538

Washington Hospital, Fremont

96819

Hawaii Permanente Medical Group-Kaiser Foundation Hospital, Honolulu

97239

Oregon Health & Science University, Portland

06030

University of Connecticut Health Center, Farmington

02114

Massachusetts General Hospital, Boston

08103

Our Lady of Lourdes Medical Center, Camden

07102

St. Michael's Medical Center, Newark

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00402740 - Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) | Biotech Hunter | Biotech Hunter